Quantitative nuclear grade (QNG): A new image analysis-based biomarker of clinically relevant nuclear structure alterations

Journal of Cellular Biochemistry

Volumn 80, Issue SUPPL. 35, 2000, Pages 151-157

  Stenoien, David L ^a   Simeoni, Silvia ^a   Sharp, Z Dave ^b   Mancini, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Algorithms; Bladder cancer; Image analysis; Logistic regression; Nuclear morphometry; Prognosis; Prostate cancer; Staging

Indexed keywords

TUMOR MARKER; BIOLOGICAL MARKER;

ALGORITHM; ARTIFICIAL NEURAL NETWORK; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CELL NUCLEUS; CELL STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REGRESSION ANALYSIS; REVIEW; AREA UNDER THE CURVE; BIOPSY; BLADDER TUMOR; CHEMISTRY; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TIME;

AREA UNDER CURVE; BIOLOGICAL MARKERS; BIOPSY; CELL NUCLEUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 37649026078     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Optical microscope system for standardized cell measurements and analyses
2. An algorithm for predicting non-organ confined prostate cancer using the results obtained from sextant core biopsies with PSA level
3. Molecular methods for the diagnosis of cancer
4. Organization of chromatin in cancer cells: Role of signaling pathways
5. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer
6. A genetic basis for multi-step pathway of colorectal tumorigenesis
7. Molecular genetic studies of the adenoma-carcinoma sequence
8. Cytogenetics of bladder cancer
9. Chromatin, nuclear matrix and cytoskeleton: Role of cell structure in neoplastic transformation
10. DNA microarray technology: The anticipated impact on the study of human disease
11. Molecular and cellular biology of prostate cancer
12. Nuclear texture: Can it be used as a surrogate endpoint biomarker?
13. Malignancy associate changes: Can they be employed clinically?
14. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: A critical analysis
15. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy
16. Artificial neural networks in urology update
17. Identification of p53 gene mutations in bladder cancers and urine samples
18. DNA ploidy enhances the cytologic prediction of recurrent transitional cell carcinoma of the bladder
19. Two molecular pathways to transitional cell carcinoma of the bladder
20. Nuclear structure-gene interrelationships: Implications for aberrant gene expression in cancer
21. Detection of bladder cancer recurrence by microsatellite analysis of urine
22. Ability to predict biochemical progression using Gleason score and computer-generated quantitative nuclear grade derived from cancer cell nuclei
23. Computer-assisted quantitative nuclear grading (QNG) can predict bladder cancer recurrence using bladder cancer cytology samples
24. The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis
25. Prediction of pathological stage in clinical stage Tlc CaP
26. Standardization, analytical validation, and quality control of intermediate endpoint biomarkers
27. The multistep nature of cancer
28. Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade TCC